星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2022-03-08 医者仁者

根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。

102 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2024-08-07 ms3000000142214475 来自广东省

投稿命中率:25.0
经验分享：刚投，观望中。。。

69 0

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2022-03-08 医者仁者

JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。

111 0

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2020-11-11 12582298m38暂无昵称

请问这个如果拒稿大概多久呀？

184 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2014-10-10 匿名用户

审稿速度:2.0 | 投稿命中率:25.0
经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。

516 0

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2014-09-05 gchx2008

投稿命中率:25.0
经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。

507 0

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2012-12-11 sunwenshan

审稿速度:2.0 | 投稿命中率:25.0
经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。

569 0

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2012-01-31 匿名用户

审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻

612 0

[GetPortalCommentsPageByObjectIdResponse(id=1200519, encodeId=3b1a120051962, content=根据官网消息，在Clinical Pharmacology & Therapeutics投稿需要提交75美元的提交费；接受出版的手稿需要支付版面费，每个期刊页面将收取 54 美元的费用；补充信息每个文件收费125美元；如需印刷纸质版需要彩图费用（如下图），不过一般是不需要的；另外，如果可以选择OnlineOpen，每篇文章收取3300美元的文章处理费，折合人民币约为20800元，从官网近期上线的文章来看，大部分还是会选择OA。整体下来发表一篇的文章确实不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:36:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219014, encodeId=a9ea2219014f6, content=投稿命中率:25.0 经验分享：刚投，观望中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7569415727, createdName=ms3000000142214475, createdTime=Wed Aug 07 22:44:44 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1200521, encodeId=8e281200521a5, content=JCR分区： PHARMACOLOGY & PHARMACY为Q1区最新中科院大小类分区 2021年12月（基础版）大类学科：医学 2区Top 小类学科：药学 1区 2021年12月（升级版）大类学科：医学 2区Top 小类学科：药学 1区审稿周期 Clinical Pharmacology & Therapeutics官网未表明审稿周期；通过对近期已发表文章审稿速度的抽样统计，大部分文章的审稿周期都是在1-3个月左右便可接受，最快的当天就已经接受！慢的需要接近4个月，审稿周期整体比较快，不过也有一部分稿件没有显示具体的过程时间，所以显示的参考有可能存在一定的偏差。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Tue Mar 08 12:38:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898458, encodeId=da06898458d0, content=请问这个如果拒稿大概多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45d42570757, createdName=12582298m38暂无昵称, createdTime=Wed Nov 11 14:35:54 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506699, encodeId=3dc250669975, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿40多天，提了一大堆意见，比较苛刻，拒稿。对稿件要求很高，命中率大约10%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=516, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 10 17:22:00 CST 2014, time=2014-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505844, encodeId=42585058440e, content=投稿命中率:25.0 经验分享：临床药理学方面的权威杂志，稿件要求高，收稿量不大，审稿周期慢，要交审稿费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583014473, createdName=gchx2008, createdTime=Fri Sep 05 08:52:00 CST 2014, time=2014-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492838, encodeId=e5f74928385f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿整七周，拒稿。审稿意见很多，也很专业。一般的临床研究，单中心小规模的研究挑战就比较有难度了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=569, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sunwenshan, createdTime=Tue Dec 11 09:50:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486449, encodeId=5c5f4864498f, content=审稿速度一般，我的文章审了1个半月，拒了，意见比较苛刻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Jan 31 08:10:00 CST 2012, time=2012-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473001, encodeId=737f4e300190, content=杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Dec 18 23:52:00 CST 2010, time=2010-12-18, status=1, ipAttribution=)]

2010-12-18 匿名用户

杂志审稿超慢，我的文章催了两次一审才结束，而且据了。专家提了一大堆不知所云的意见，劝大家不要投它了。

659 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务